ULTRAGENYX PHARMACEUTICAL INC. 4,444,444 Shares of Common Stock Underwriting AgreementUltragenyx Pharmaceutical Inc. • November 2nd, 2020 • Pharmaceutical preparations • New York
Ultragenyx Pharmaceutical Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”) an aggregate of 4,444,444 shares (the “Underwritten Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”). In addition, the Company proposes to issue and sell, at the option of the Underwriters, up to an additional 666,666 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.”
